Trial reportBMC oral health2026
The Effect of injectable platelet-rich fibrin and low-level laser therapy on graft shrinkage in free gingival grafts: a randomized controlled clinical trial.
Trial report in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07303192 (The Effect of Injectable Platelet-Rich Fibrin and Low-Level Laser Therapy on Graft Shrinkage in Free Gingival Grafts), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Effect of Injectable Platelet-Rich Fibrin and Low-Level Laser Therapy on Graft Shrinkage in Free Gingival Grafts: A Randomized Controlled Clinical Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this randomized, controlled clinical study was to evaluate and compare the effects of injectable platelet-rich fibrin (i-PRF) applied over free gingival grafts (FGG) on graft shrinkage, root coverage, and postoperative comfort, in comparison with low-level laser therapy (LLLT) and a control group.
methodsA total of 48 patients aged 19–41 years with Cairo et al. Gingival Recession Type 1 (RT1) were randomly allocated into control (n = 16), i-PRF (n = 15), and LLLT (n = 17) groups. The primary outcome was graft shrinkage. Secondary outcomes included gingival recession depth (RD), keratinized tissue height (KTH), probing depth (PD), clinical attachment level (CAL), and postoperative outcomes (oedema, erythema, pain, and analgesic consumption). LLLT was applied immediately after surgery and on days 3, 7, and 14 using a 940 nm diode laser (0.21 W, 5 J/cm²). The i-PRF was prepared by centrifuging venous blood at 700 rpm for 3 min and was then applied in gel form onto the graft surface. Graft areas were measured at baseline and at 1, 3, and 6 months using image analysis software. Postoperative oedema, erythema, pain, and analgesic consumption were also evaluated.
resultsGraft shrinkage was significantly higher in control subjects than in both treatment groups, and significantly higher in LLLT than i-PRF at all timepoints. Postoperative edema, erythema, and VAS scores showed no significant intergroup differences. Analgesic use was higher in the control group than in i-PRF. KTH values were greater and RD values lower in the i-PRF group compared with the control and LLLT groups.
conclusioni-PRF reduced graft shrinkage, enhanced root coverage, and improved postoperative comfort, whereas LLLT contributed minimally to graft stability. i-PRF appears to be an effective biological adjunct in FGG surgery.
trial registrationRetrospectively registered at ClinicalTrials.gov (Identifier NCT07303192 Date of registration 20251211).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.